Reza Dana is the Claes H. Dohlman Chair in Ophthalmology, Senior Scientist and W. Clement Stone Clinical Research Scholar, Director of Cornea at Massachusetts Eye and Ear, Vice Chair for Academic Programs at the Department of Ophthalmology, Harvard Medical School, and Director of the Harvard-Vision Clinical Scientist Development Program.[1]
Dana is an internationally recognized expert in the field of corneal disorders and ocular inflammation. He is best known for his work on the mechanisms of ocular inflammation with translational applications to transplantation, autoimmunity, and angiogenesis.[2] He is a member of editorial boards of 10 journals, including as editor-in-chief of Cornea.[3][4]
Dana joined the ophthalmology faculty at the Harvard Medical School as an Instructor in 1995 and has been a faculty member there ever since. In 2006, he was named the director of the Cornea Service at Massachusetts Eye and Ear, and in 2007, he was appointed the Claes H. Dohlman Chair in Ophthalmology and Vice Chairman for Academic Programs.
Dana's research focus is in the area of immuno-inflammatory disorders of the cornea and ocular surface. He has published over 400 peer-reviewed publications and over 150 reviews, and edited several books.[7][8] His work has been cited more than 53000 times and carries an h-index of 110 as per Google Scholar.[9] His is widely recognized for (i) identifying, phenotyping and functionally characterizing resident bone marrow-derived antigen-presenting cells (APC) of the cornea,[10] (ii) identifying novel mechanisms of corneal APC trafficking,[11] (iii) defining novel functional interactions between lymphatic endothelia and APC,[12] (iv) identifying selective topical cytokine and chemokine targeting to promote transplant survival by suppressing effector T cells,[13][14][15][16] (v) defining novel mechanisms employed by the corneal epithelium to maintain angiogenic privilege including the VEGFR-3 sink[17] and PD-L1 mechanisms,[18] (vi) developing strategies to promote corneal endothelial cell survival in transplantation, including gene therapy.[19][20] (vi) demonstrating the function of memory Th17 cells in pathogenesis of ocular surface autoimmunity.[21][22][23] (vii) evaluating the role of regulatory T cells in corneal graft tolerance.[24][25][26] (viii) insights into the contribution of diabetes to alterations in corneal graft immunity.[27] (ix) developing novel biomaterials for therapeutics delivery to the eye.[28][29]
2016 – Elected, Academia Ophthalmologica Internationalis[41]
2016 – Mooney Lecture, Irish College of Ophthalmologists, Republic of Ireland[42]Dr. Dana presenting the Inaugural Joseph Markoff, PhD, MD Endowed Lecture with the Vickie & Jack Farber Vision Research Center at Wills Eye Hospital, Philadelphia, PA.
2025 – Harvard Ophthalmology Lifetime Achievement Award in Mentoring
2025 – Thomas H. Pettit Lecture, UCLA Stein and Doheny Eye Institutes Annual Meeting Dr. Dana receiving the Richard Lindstrom Award 2025 at American Society of Cataract & Refractive Surgery Annual Meeting, Los Angeles, CA.
Teaching and Mentoring
Dana is the Vice Chair for Academic Programs at the Department of Ophthalmology, Massachusetts Eye and Ear and a faculty for the Graduate Program in Immunology, Harvard Medical School.[2] He is the recipient of the Harvard Medical School Clifford Barger Excellence in Mentoring Award, the top mentoring award bestowed at Harvard Medical School.[38] He has mentored over 150 postdoctoral research fellows from 36 countries, 250 clinical fellows and residents, medical students, and graduate students. He has been the director of the National Institutes of Health-funded Harvard-Vision Clinical Scientist Development Program since 2004.[58]
1 2 3 Streilein, J. Wayne (2004-03-01). "Introducing Reza Dana, the 2003 Recipient of the Cogan Award". Investigative Ophthalmology & Visual Science. 45 (3): 721. doi:10.1167/iovs.03-0509. ISSN1552-5783.
↑ Hamrah, Pedram; Huq, Syed O.; Liu, Ying; Zhang, Qiang; Dana, M. Reza (2003). "Corneal immunity is mediated by heterogeneous population of antigen-presenting cells". Journal of Leukocyte Biology. 74 (2): 172–178. doi:10.1189/jlb.1102544. ISSN0741-5400. PMID12885933. S2CID15964172.
↑ Chen, Lu; Hamrah, Pedram; Cursiefen, Claus; Zhang, Qiang; Pytowski, Bronislaw; Streilein, J. Wayne; Dana, M. Reza (2004). "Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity". Nature Medicine. 10 (8): 813–815. doi:10.1038/nm1078. ISSN1078-8956. PMID15235599. S2CID1449221.
↑ Huq, Syed; Liu, Ying; Benichou, Gilles; Dana, M. Reza (2004-10-01). "Relevance of the Direct Pathway of Sensitization in Corneal Transplantation Is Dictated by the Graft Bed Microenvironment". The Journal of Immunology. 173 (7): 4464–4469. doi:10.4049/jimmunol.173.7.4464. ISSN0022-1767. PMID15383577.
This page is based on this Wikipedia article Text is available under the CC BY-SA 4.0 license; additional terms may apply. Images, videos and audio are available under their respective licenses.